Composition: Ondansetron IP 4 mg
Ondidrop-4 Ondidrop-4 contains Ondansetron, a potent and selective 5-HT3 receptor antagonist widely prescribed to prevent and treat nausea and vomiting caused by cancer chemotherapy, radiation therapy, and post-operative surgical recovery. Formulated as an orally disintegrating tablet, it dissolves rapidly in the mouth without requiring water, offering fast-acting relief and convenience for patients experiencing acute gastric distress or difficulty swallowing traditional pills.
Find answers regarding product efficacy, clinical specifications, and distribution rights.